Utilizing Metformin to Enhance Fracture Callus Development through AMPK-Mediated Metabolic Stimulation
By
Vasyl Pastukh
Jianying Zhang
Peter G. Alexander
Satyaj Bhargava
Arshia Shams
Celina Zhao
MaCalus V. Hogan
James H-C. Wang
July 1, 2026
Clinical Scorecard: Utilizing Metformin to Enhance Fracture Callus Development through AMPK-Mediated Metabolic Stimulation
At a Glance
Category Detail
Condition Femoral Shaft Fractures Key Mechanisms AMPK activation, mitochondrial biogenesis, inflammation suppression Target Population Young adults and older adults with femoral shaft fractures Care Setting Orthopedic trauma care
Key Highlights
Metformin enhances angiogenesis and osteogenic differentiation. AMPK activation is central to Met's cellular effects. Metformin may improve skeletal repair under metabolic and inflammatory stress. Open fractures have high risks of infection and delayed healing. Therapeutic strategies to enhance bone regeneration are urgently needed. Guideline-Based Recommendations
Diagnosis
Assessment of fracture type and severity is crucial. Management
Intramedullary nailing is the gold-standard fixation method. Monitoring & Follow-up
Regular evaluation of healing progress and potential complications. Risks
High risks of infection, delayed union, and non-union in open fractures. Patient & Prescribing Data
Female Sprague-Dawley rats used in preclinical studies.
Metformin may serve as a systemically deliverable adjunct therapy.
Clinical Best Practices
Utilize standardized open osteotomy models for reproducibility. Implement post-surgical antibiotics and analgesics to prevent infection. Related Resources & Content
